nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonordefrin—ADRA2A—Metabolism—ADH7—esophageal cancer	0.00124	0.00124	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ADCYAP1—esophageal cancer	0.00122	0.00122	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—GHRL—esophageal cancer	0.00121	0.00121	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—ABL1—esophageal cancer	0.00121	0.00121	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PDE4D—esophageal cancer	0.00121	0.00121	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—SST—esophageal cancer	0.00121	0.00121	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—ALOX15—esophageal cancer	0.00121	0.00121	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—CXCL2—esophageal cancer	0.0012	0.0012	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—WWOX—esophageal cancer	0.0012	0.0012	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—GHRL—esophageal cancer	0.00118	0.00118	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PFN1—esophageal cancer	0.00118	0.00118	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CSNK1A1—esophageal cancer	0.00117	0.00117	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—ANXA1—esophageal cancer	0.00116	0.00116	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—GNG7—esophageal cancer	0.00115	0.00115	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—TPI1—esophageal cancer	0.00115	0.00115	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GSTO1—esophageal cancer	0.00115	0.00115	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—NOS2—esophageal cancer	0.00115	0.00115	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—FKBP1A—esophageal cancer	0.00114	0.00114	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—SST—esophageal cancer	0.00113	0.00113	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—ANXA1—esophageal cancer	0.00112	0.00112	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—CXCL2—esophageal cancer	0.00112	0.00112	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—WIF1—esophageal cancer	0.00111	0.00111	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—WWOX—esophageal cancer	0.00111	0.00111	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—ALDOB—esophageal cancer	0.00111	0.00111	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—GHRL—esophageal cancer	0.0011	0.0011	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PFN1—esophageal cancer	0.0011	0.0011	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CXCL2—esophageal cancer	0.00109	0.00109	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—SST—esophageal cancer	0.00109	0.00109	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ADH1B—esophageal cancer	0.00108	0.00108	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—NOS2—esophageal cancer	0.00108	0.00108	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.00107	0.00107	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GAPDH—esophageal cancer	0.00106	0.00106	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—GHRL—esophageal cancer	0.00106	0.00106	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—FKBP1A—esophageal cancer	0.00106	0.00106	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ELMO1—esophageal cancer	0.00106	0.00106	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CRABP1—esophageal cancer	0.00105	0.00105	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—ANXA1—esophageal cancer	0.00104	0.00104	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—TYMP—esophageal cancer	0.00104	0.00104	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—CREBBP—esophageal cancer	0.00104	0.00104	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—WIF1—esophageal cancer	0.00103	0.00103	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—AKAP13—esophageal cancer	0.00103	0.00103	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CSNK1A1—esophageal cancer	0.00103	0.00103	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—ANXA1—esophageal cancer	0.00102	0.00102	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CXCL2—esophageal cancer	0.00102	0.00102	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—SST—esophageal cancer	0.00101	0.00101	CbGpPWpGaD
Levonordefrin—ADRA2B—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	0.00101	0.00101	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CYP26A1—esophageal cancer	0.00101	0.00101	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GNG7—esophageal cancer	0.001	0.001	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—SST—esophageal cancer	0.000989	0.000989	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ELMO1—esophageal cancer	0.000987	0.000987	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—GHRL—esophageal cancer	0.000986	0.000986	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ALOX15—esophageal cancer	0.000982	0.000982	CbGpPWpGaD
Levonordefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000973	0.000973	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—CREBBP—esophageal cancer	0.000967	0.000967	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—AKAP13—esophageal cancer	0.000964	0.000964	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—GHRL—esophageal cancer	0.000964	0.000964	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PFN1—esophageal cancer	0.00096	0.00096	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CSNK1A1—esophageal cancer	0.000954	0.000954	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000953	0.000953	CbGpPWpGaD
Levonordefrin—ADRA2C—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	0.000945	0.000945	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—ANXA1—esophageal cancer	0.000945	0.000945	CbGpPWpGaD
Levonordefrin—ADRA1A—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000944	0.000944	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PDE4D—esophageal cancer	0.000944	0.000944	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—ALDH2—esophageal cancer	0.00094	0.00094	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GSTO1—esophageal cancer	0.000937	0.000937	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—TPI1—esophageal cancer	0.000937	0.000937	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—NOS3—esophageal cancer	0.000927	0.000927	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—SST—esophageal cancer	0.000919	0.000919	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—GNG7—esophageal cancer	0.000898	0.000898	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ALDOB—esophageal cancer	0.000898	0.000898	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—GHRL—esophageal cancer	0.000896	0.000896	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GSTT1—esophageal cancer	0.000894	0.000894	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PFN1—esophageal cancer	0.000892	0.000892	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—HIST1H2BM—esophageal cancer	0.00089	0.00089	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CYP2A6—esophageal cancer	0.000884	0.000884	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PDE4D—esophageal cancer	0.000882	0.000882	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—NOS2—esophageal cancer	0.000875	0.000875	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—NOS3—esophageal cancer	0.000866	0.000866	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GAPDH—esophageal cancer	0.000864	0.000864	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ELMO1—esophageal cancer	0.000862	0.000862	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CRABP1—esophageal cancer	0.000857	0.000857	CbGpPWpGaD
Levonordefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000845	0.000845	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—AKAP13—esophageal cancer	0.000843	0.000843	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—XIAP—esophageal cancer	0.000841	0.000841	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—GNG7—esophageal cancer	0.000839	0.000839	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—ENO1—esophageal cancer	0.000838	0.000838	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PTGS1—esophageal cancer	0.000838	0.000838	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PSME1—esophageal cancer	0.000826	0.000826	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PSME2—esophageal cancer	0.000826	0.000826	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GNG7—esophageal cancer	0.000815	0.000815	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ELMO1—esophageal cancer	0.000801	0.000801	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CTNNA1—esophageal cancer	0.000796	0.000796	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CXCL2—esophageal cancer	0.000791	0.000791	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—XIAP—esophageal cancer	0.000786	0.000786	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—CREBBP—esophageal cancer	0.000786	0.000786	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—AKAP13—esophageal cancer	0.000783	0.000783	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000778	0.000778	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PDE4D—esophageal cancer	0.000771	0.000771	CbGpPWpGaD
Levonordefrin—ADRA2A—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	0.000768	0.000768	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ALDH2—esophageal cancer	0.000764	0.000764	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CTNNA1—esophageal cancer	0.000743	0.000743	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PSME2—esophageal cancer	0.000739	0.000739	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PSME1—esophageal cancer	0.000739	0.000739	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CXCL2—esophageal cancer	0.000739	0.000739	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ANXA1—esophageal cancer	0.000736	0.000736	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—GNG7—esophageal cancer	0.000733	0.000733	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GSTT1—esophageal cancer	0.000726	0.000726	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000723	0.000723	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CYP2A6—esophageal cancer	0.000718	0.000718	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PDE4D—esophageal cancer	0.000716	0.000716	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—SST—esophageal cancer	0.000716	0.000716	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CYP1B1—esophageal cancer	0.000712	0.000712	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—EP300—esophageal cancer	0.000705	0.000705	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—NOS3—esophageal cancer	0.000703	0.000703	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NOTCH3—esophageal cancer	0.000697	0.000697	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—GHRL—esophageal cancer	0.000697	0.000697	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PSME1—esophageal cancer	0.00069	0.00069	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PSME2—esophageal cancer	0.00069	0.00069	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—XIAP—esophageal cancer	0.000687	0.000687	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ANXA1—esophageal cancer	0.000687	0.000687	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—FBXW7—esophageal cancer	0.000686	0.000686	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—GNG7—esophageal cancer	0.000681	0.000681	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ENO1—esophageal cancer	0.000681	0.000681	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PTGS1—esophageal cancer	0.000681	0.000681	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PSME2—esophageal cancer	0.000671	0.000671	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PSME1—esophageal cancer	0.000671	0.000671	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CYP19A1—esophageal cancer	0.00067	0.00067	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—SST—esophageal cancer	0.000668	0.000668	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—EP300—esophageal cancer	0.000659	0.000659	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NOTCH3—esophageal cancer	0.000651	0.000651	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—GHRL—esophageal cancer	0.000651	0.000651	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CTNNA1—esophageal cancer	0.00065	0.00065	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CXCL2—esophageal cancer	0.000646	0.000646	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—FBXW7—esophageal cancer	0.000641	0.000641	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—XIAP—esophageal cancer	0.000638	0.000638	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NOTCH2—esophageal cancer	0.000625	0.000625	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—HMOX1—esophageal cancer	0.000611	0.000611	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CTNNA1—esophageal cancer	0.000604	0.000604	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PSME1—esophageal cancer	0.000604	0.000604	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PSME2—esophageal cancer	0.000604	0.000604	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ANXA1—esophageal cancer	0.000601	0.000601	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CXCL2—esophageal cancer	0.0006	0.0006	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—ABCB1—esophageal cancer	0.000587	0.000587	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—SST—esophageal cancer	0.000584	0.000584	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NOTCH2—esophageal cancer	0.000584	0.000584	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CYP1B1—esophageal cancer	0.000579	0.000579	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—GHRL—esophageal cancer	0.000569	0.000569	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NOTCH3—esophageal cancer	0.000569	0.000569	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PSME2—esophageal cancer	0.000561	0.000561	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PSME1—esophageal cancer	0.000561	0.000561	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—FBXW7—esophageal cancer	0.00056	0.00056	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ANXA1—esophageal cancer	0.000558	0.000558	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—TGFBR2—esophageal cancer	0.000555	0.000555	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CYP19A1—esophageal cancer	0.000544	0.000544	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—SST—esophageal cancer	0.000543	0.000543	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—EP300—esophageal cancer	0.000535	0.000535	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—GHRL—esophageal cancer	0.000529	0.000529	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NOTCH3—esophageal cancer	0.000529	0.000529	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—SMAD4—esophageal cancer	0.000525	0.000525	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—PIK3CA—esophageal cancer	0.000522	0.000522	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—FBXW7—esophageal cancer	0.00052	0.00052	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—TGFBR2—esophageal cancer	0.000518	0.000518	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NOTCH2—esophageal cancer	0.000511	0.000511	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—TP53—esophageal cancer	0.000505	0.000505	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—HMOX1—esophageal cancer	0.000496	0.000496	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—SMAD4—esophageal cancer	0.000491	0.000491	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—PIK3CA—esophageal cancer	0.000487	0.000487	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ABCB1—esophageal cancer	0.000477	0.000477	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NOTCH2—esophageal cancer	0.000475	0.000475	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—TP53—esophageal cancer	0.000471	0.000471	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—TGFBR2—esophageal cancer	0.000453	0.000453	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—HIF1A—esophageal cancer	0.00043	0.00043	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—SMAD4—esophageal cancer	0.000429	0.000429	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—TGFBR2—esophageal cancer	0.000421	0.000421	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—KDR—esophageal cancer	0.000411	0.000411	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—HIF1A—esophageal cancer	0.000401	0.000401	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—SMAD4—esophageal cancer	0.000398	0.000398	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—PIK3CA—esophageal cancer	0.000396	0.000396	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CREBBP—esophageal cancer	0.000392	0.000392	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NOTCH1—esophageal cancer	0.000387	0.000387	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—KDR—esophageal cancer	0.000384	0.000384	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—TP53—esophageal cancer	0.000383	0.000383	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NOTCH1—esophageal cancer	0.000362	0.000362	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—NOS3—esophageal cancer	0.000351	0.000351	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CREBBP—esophageal cancer	0.000351	0.000351	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—HIF1A—esophageal cancer	0.000351	0.000351	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—EGFR—esophageal cancer	0.000345	0.000345	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—KDR—esophageal cancer	0.000336	0.000336	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—PIK3CA—esophageal cancer	0.00033	0.00033	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CREBBP—esophageal cancer	0.000328	0.000328	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—HIF1A—esophageal cancer	0.000326	0.000326	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—EGFR—esophageal cancer	0.000322	0.000322	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PTGS2—esophageal cancer	0.000321	0.000321	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CREBBP—esophageal cancer	0.000318	0.000318	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NOTCH1—esophageal cancer	0.000316	0.000316	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NOS3—esophageal cancer	0.000314	0.000314	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—KDR—esophageal cancer	0.000312	0.000312	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000308	0.000308	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—PIK3CA—esophageal cancer	0.000299	0.000299	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ERBB2—esophageal cancer	0.000294	0.000294	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NOTCH1—esophageal cancer	0.000294	0.000294	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NOS3—esophageal cancer	0.000294	0.000294	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CREBBP—esophageal cancer	0.000287	0.000287	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—NOS3—esophageal cancer	0.000285	0.000285	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—EGFR—esophageal cancer	0.000282	0.000282	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—PIK3CA—esophageal cancer	0.00028	0.00028	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ERBB2—esophageal cancer	0.000275	0.000275	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000269	0.000269	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—EP300—esophageal cancer	0.000267	0.000267	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CREBBP—esophageal cancer	0.000266	0.000266	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—EGFR—esophageal cancer	0.000262	0.000262	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PTGS2—esophageal cancer	0.000261	0.000261	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CCND1—esophageal cancer	0.00026	0.00026	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NOS3—esophageal cancer	0.000257	0.000257	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CDKN1A—esophageal cancer	0.000251	0.000251	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—PIK3CA—esophageal cancer	0.00025	0.00025	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—PIK3CA—esophageal cancer	0.000244	0.000244	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CCND1—esophageal cancer	0.000243	0.000243	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ERBB2—esophageal cancer	0.00024	0.00024	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—EP300—esophageal cancer	0.000239	0.000239	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NOS3—esophageal cancer	0.000238	0.000238	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CDKN1A—esophageal cancer	0.000235	0.000235	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PIK3CA—esophageal cancer	0.000227	0.000227	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—EP300—esophageal cancer	0.000223	0.000223	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ERBB2—esophageal cancer	0.000223	0.000223	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—EP300—esophageal cancer	0.000217	0.000217	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CCND1—esophageal cancer	0.000212	0.000212	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MYC—esophageal cancer	0.000208	0.000208	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CDKN1A—esophageal cancer	0.000205	0.000205	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—EGFR—esophageal cancer	0.000204	0.000204	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PIK3CA—esophageal cancer	0.000198	0.000198	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CCND1—esophageal cancer	0.000197	0.000197	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—EP300—esophageal cancer	0.000195	0.000195	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MYC—esophageal cancer	0.000195	0.000195	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CDKN1A—esophageal cancer	0.000191	0.000191	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—EGFR—esophageal cancer	0.00019	0.00019	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—EP300—esophageal cancer	0.000181	0.000181	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PIK3CA—esophageal cancer	0.000177	0.000177	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—TP53—esophageal cancer	0.000171	0.000171	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MYC—esophageal cancer	0.00017	0.00017	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—EGFR—esophageal cancer	0.000166	0.000166	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PIK3CA—esophageal cancer	0.000165	0.000165	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PIK3CA—esophageal cancer	0.00016	0.00016	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—TP53—esophageal cancer	0.00016	0.00016	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MYC—esophageal cancer	0.000158	0.000158	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—EGFR—esophageal cancer	0.000155	0.000155	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PIK3CA—esophageal cancer	0.000144	0.000144	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—TP53—esophageal cancer	0.00014	0.00014	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PIK3CA—esophageal cancer	0.000134	0.000134	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—TP53—esophageal cancer	0.00013	0.00013	CbGpPWpGaD
